These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34782638)

  • 1. Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B.
    Argirion I; Pfeiffer RM; Lam TK; O'Brien TR; Yu K; McGlynn KA; Petrick JL; Pinto L; Chen CJ; Lee MH; Hildesheim A; Yang HI; Koshiol J
    Sci Rep; 2021 Nov; 11(1):21194. PubMed ID: 34782638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals.
    Koshiol J; Argirion I; Liu Z; Kim Lam T; O'Brien TR; Yu K; McGlynn KA; Petrick JL; Pinto L; Chen CJ; Hildesheim A; Pfeiffer RM; Lee MH; Yang HI
    Aliment Pharmacol Ther; 2021 Sep; 54(6):833-842. PubMed ID: 34286851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C Cohort.
    Argirion I; Brown J; Jackson S; Pfeiffer RM; Lam TK; O'Brien TR; Yu KJ; McGlynn KA; Petrick JL; Pinto LA; Chen CJ; Hildesheim A; Yang HI; Lee MH; Koshiol J
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
    Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
    Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What can we learn from hepatitis B virus clinical cohorts?
    Lin CL; Tseng TC; Kao JH
    Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis.
    Tseng TC; Liu CJ; Chang CT; Su TH; Yang WT; Tsai CH; Chen CL; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
    J Hepatol; 2020 Jun; 72(6):1105-1111. PubMed ID: 32006586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B.
    Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
    Lok AS; Perrillo R; Lalama CM; Fried MW; Belle SH; Ghany MG; Khalili M; Fontana RJ; Sterling RK; Terrault N; Feld JJ; Di Bisceglie AM; Lau DTY; Hassan M; Janssen HLA;
    Hepatology; 2021 Jun; 73(6):2124-2140. PubMed ID: 32936969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma: a cross-sectional case-control study from Chinese patients with HBV infection.
    Gao C; Fang L; Zhao HC; Li JT; Yao SK
    Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):385-93. PubMed ID: 23924496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative cross-sectional study of the development of hepatocellular carcinoma in patients with liver cirrhosis caused by hepatitis B virus, alcohol, or combination of hepatitis b virus and alcohol].
    Chung NS; Kwon OS; Park CH; Kim YN; Cho GH; Lee JJ; Kim GH; Kim HO; Ko KI; Yu SK; Kwon KA; Kim YS; Choi DJ; Kim JH
    Korean J Gastroenterol; 2007 Jun; 49(6):369-75. PubMed ID: 17641555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
    Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
    BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.
    Jeon MY; Lee HW; Kim SU; Heo JY; Han S; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
    Hepatol Int; 2017 May; 11(3):268-276. PubMed ID: 28224351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
    Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
    Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
    Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
    Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives and control of hepatitis B virus infection in Taiwan.
    Lin CL; Kao JH
    J Formos Med Assoc; 2015 Oct; 114(10):901-9. PubMed ID: 26184565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration.
    Zampino R; Pisaturo MA; Cirillo G; Marrone A; Macera M; Rinaldi L; Stanzione M; Durante-Mangoni E; Gentile I; Sagnelli E; Signoriello G; Miraglia Del Giudice E; Adinolfi LE; Coppola N
    Ann Hepatol; 2015; 14(1):75-82. PubMed ID: 25536644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.
    Paik N; Sinn DH; Lee JH; Oh IS; Kim JH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Liver Int; 2018 Jan; 38(1):68-75. PubMed ID: 28581248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.